In our study, 27 infants (2.7%) were born with a major congenital abnormality, which is consistent with data reported from the overall European population.30 Anti-TNF-α and/or thiopurine use for IBD during pregnancy was not associated with the outcome major congenital abnormalities of their offspring. This evidence concerns the gene TNF and inflammatory bowel disease.